Grimplants LLC – Trademark Portfolio

Entity Type: 16

Grimplants LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 3 are pending. Notable registered marks include GRIMPLANTS and THE NEXT STEP IN SURGICAL SCIENCE. The owner is based in Bulverde, TX.

32200 Cardamon Way

Bulverde, TX 78163

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Grimplants LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Grimplants LLC have?

Grimplants LLC has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 pending, 1 abandoned.

What trademark classes does Grimplants LLC file in?

Grimplants LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Grimplants LLC's most well-known trademarks?

Grimplants LLC's registered trademark portfolio includes well-known marks such as GRIMPLANTS and THE NEXT STEP IN SURGICAL SCIENCE. These are among 3 currently registered trademarks in the portfolio.

What is Grimplants LLC's trademark registration success rate?

Grimplants LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 3 applications are pending review.